Preview

Нефрология

Расширенный поиск

ПРОБЛЕМА ОЦЕНКИ СКОРОСТИ КЛУБОЧКОВОЙ ФИЛЬТРАЦИИ В СОВРЕМЕННОЙ НЕФРОЛОГИИ: НОВЫЙ ИНДИКАТОР ЦИСТАТИН С

https://doi.org/10.24884/1561-6274-2005-9-3-16-27

Полный текст:

Аннотация

Проблема оценки скорости клубочковой фильтрации в современной нефрологии: новый индикатор цистатин С.

Об авторах

А. В. Смирнов
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Кафедры пропедевтики внутренних болезней, нефрологии и диализа


И. Г. Каюков
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Кафедры пропедевтики внутренних болезней, нефрологии и диализа


А. М. Есаян
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Кафедры пропедевтики внутренних болезней, нефрологии и диализа


А. Г. Кучер
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Кафедры пропедевтики внутренних болезней, нефрологии и диализа


О. А. Дегтерева
Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Кафедры пропедевтики внутренних болезней, нефрологии и диализа


Список литературы

1. National Kidney Foundation KD: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002: 39 [Suppl 1]: S1S266

2. Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая бо лезнь почек: на пути к единству представлений. Нефроло

3. гия 2002; 6(4): 1117

4. Смирнов АВ, Каюков ИГ, Есаян АМ, Добронравов ВА, Кучер АГ, Тугушева ФА. Превентивный подход в современ ной нефрологии. Нефрология 2004; 8(3): 714

5. Смирнов АВ. Хроническая болезнь почек или хрони ческое заболевание почек? Нефрология 2004; 8(1): 101102

6. Земченков А.Ю., Томилина Н.А. «К/ДОКИ» обращает ся к истокам хронической почечной недостаточности (О но вом разделе Рекомендаций K/DOQI по диагностике, классификации и оценке тяжести хронических заболева ний почек). Нефрология и диализ 2004; 6(3): 204220

7. Томилина НА, Бикбов БТ. Эпидемиология хроничес кой почечной недостаточности и новые подходы к класси фикации и оценке тяжести хронических прогрессирующих заболеваний почек. Тер арх 2005; 77(6): 8792

8. Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM, ed. The kidney, fifth ed., Brenner&Rector, W.B. Saunders, 1998; 2147722269

9. Carlson JA, Harrington JT. Laboratory evaluation of renal function. In: Schrier RW, Gottschalk CW, eds. Disease of the kidney, fifth ed. Little, Brown&Co, Boston e.a., 1993; 361405

10. Perrone R, Steinman TI, Beck GJ et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125Iiothalamate, 169YbDTPA, 99mTc DTPA and inulin. The Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1990; 16: 224235

11. Levey AS, Greene T, Schluchter MD et al. Glomerular filtration rate measurement in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 1993; 4: 11591171

12. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38: S20S27

13. Mussap M, Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004;41(56):467550

14. Mareљ J, Stejskal D, Vavrauљkova J et al. Use of cystatin C determination in clinical diagnostics. Biomed Papers 2003; 147(2): 177180

15. Lie MA, Locs BG, Henskens YM et al. Salivary cystatin activity and and cystatin C in natural and experimental gingivitis in smokers and nonsmokers. J Clin Periodontol 2001; 28: 979 984

16. Uchida К, Goton A. Measurements of cystatinC and creatinine in urine. Clin Chim Acta 2002; 323 (12): 121128

17. Tkaczyk M, Nowicki M, Lukamowicz J. Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol 2004; 19(11): 12781280

18. HergetRosental S, Feldcamp T, Volbracht L, Kribben A. Measurement of urinary cystanin C by particleenhanced nephelometric immunoassay: precision, interference, stability and reference range. Ann Clin Biochem 2004; 41(Pt 2): 111118

19. HergetRosental S, Poppen D, Husing J et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004b; 50: 552558

20. Hellerstein S, Berenbom M, Erwin P et al. The ratio of urinary cystatin C to urinary creatinine for detection of decreased GFR. Pediatr Nephrol 2004; 19(5): 521525

21. Abrahamson M, Olafsson I, Palsdottir A et al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287294

22. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystain C (іtrace) as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1985; 45: 97101

23. Grubb A, Simonsen O, Sturfelt G et al. Serum concentration of cystatin C, factor D and І2microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985; 218: 499503

24. Tian S, Kusano E, Ohara T et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997; 48(2): 104108

25. Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998; 58(7):585592

26. Rodrigo E, Martin de Francisco AL, Escallada R et al. Measurement of renal function in preESRD patients. Kidney Int 2002; 61[Suppl 80]: S11S17

27. Takuwa S, Ito Y, Ushijima K, Uchida K. Serum cystatin C values in children by age and their fluctuation during dehydration. Pediatr Int 2002; 44(1): 2831

28. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a metaanalysis. Am J Kidney Dis 2002; 40(2): 221226

29. Filler G, Bokenkamp A, Hofmann W et al. Cystatin C as a marker of GFR – history, indications, and future research. Clin Biochem 2005; 38 (1): 18

30. Laterza OF, Price CP, Scott MG. Cystatin C: improved estimator of glomerular filtration rate? [Review]. Clin Chem 2002; 48: 669707

31. Gokkusu CA, Ozden TA, Gul H, Yildiz A. Relationship between plasma cystatin C and creatinine in chronic renal diseases and Txtransplant patients. Clin Biochem 2004; 37(2): 9497

32. Stabuc B, Vrhovec L, StabucSilin M, Cizey TE. Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy. Clin Chem 2000; 46 (2): 193197

33. Hermida J, Romero R, Tutor JC. Relationship between cystatin C and creatinine in kidneyliver transplant patients. Clin Chim Acta 2002; 316(12): 165170

34. ShimizuTokiwa A, Kobata M, Io H et al. Serum cystatin C is more sensitive marker of glomerular function than serum creatinine. Nephron 2002; 92(1): 224226

35. Akbas SH, Yavuz A, Tuncer M et al. Serum cystatin C as an index of renal function in kidney transplant patients. Transplant Proc 2004; 36(1): 99101

36. AlTondary YA, Hammad AM, Zaghloul YM et al. Pretreatment cystatin C in children with malignancy: can it predict chemotherapyinduced glomerular filtration rate reduction during induction phase? J Pediatr Hematol Oncol 2004; 26(6): 336341

37. Wasen E, Isoaho R, Mattila K et al. Estimation of glomerular filtration rate in the elderly: a combination of creatininebased formulae with serum cystatin C. J Intern Med 2004; 256 (1): 7078

38. Podracka L, Feber J, Lepage N, Filler G. Intraindividual variation of cystatin C and creatinine in pediatric solid organ transplant recipietnts. Pediatr Transplant 2005; 9(1): 2832

39. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 20242031

40. Larsson A, Malm J, Crubb A, Hansson L.O. Calculation of glomerular filtration rate expressed in ml/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64(1): 2530

41. Woitas RP, StoffelWagner B, Flommersfeld S et al. Correlation of serum cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000; 46 (5): 712715

42. Samyn M, Cheeseman P, Bevis L et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005; 11(3):344349

43. Newman DJ, Thakkar H, Edwards RG et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47(1):312318

44. Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol 1998; 49(4): 221225

45. Hojs R, Bevic S, Antolinc B et al. Serum cystatin C as an endogenous marker of renal function in the elderly. Int J Clin Pharmacol Res 2004; 24(23): 4954

46. Нarmoinen A, Lehtimaki T, Korpela M et al. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the CockcroftGault and Levey (MDRD) formulas. Clin Chem 2003; 49(7): 12231225

47. Schuck O, Teplan V, Jabor A et al. Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystain C levels. Nephron Clin Pract 2003; 93(4): 122123

48. Schuck O, Teplan V, Sibova J, Stollova M. Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment. Int J Clin Pharmacol Ther 2004; 42(2): 97 93

49. Plebani M, Dall’Amico R, Mussap M et al. Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients. Ren Fail 1998; 20(2):303309

50. Stickle D, Cole B, Hock K et al. Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 1998; 44 (6): 13341338

51. Burkhardt H, Bojarsky G, Gretz N, Gladisch R. Creatinine clearance, CockcroftGault formula and cystatin C: estimators of true glomerular filtration rate in the elderly. Gerontology 2002; 48(3): 140146

52. Watanabe S, Okura T, Liu J et al. Serum cystatin C level is a marker of endorgan damage in patients with essential hypertension. Hypertens Res 2003; 26 (11): 895899

53. Gabutti L, Ferrari L, Ferrari N et al. Does cystatin C improve the precision of Cockcroft and Gault’s creatinine clearance estimation? J Nephrol 2004; 17: 673678

54. Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002; 50(1): 106110

55. Rich L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplantation using serum cystatin C. Nephrol Dial Transplant 1999; 14: 19911996

56. Oddoze C, Morange S, Portugal H et al. Cystatin C is more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001; 38: 310316

57. Chantrel F, Agin A, Offner M et al. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol 2000; 54: 374381

58. Denium J, Derks FH. Cystatin for estimation of glomerular filtration rate. Lancet 2000; 356: 16241625

59. Finney Н, Newman DJ, Gruber W et al. Initial evaluation of cystanin C measurement by particleenhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43: 10161022

60. KyhseAndersen J, Schmidt C, Nordin G et al. Serum cystatin C, determined by a rapid, automated particleenhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40(10):19211926

61. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998; 44: 15351539

62. Bokenkamp M, Domanetzki M, Zinck R et al. Cystatin C serum concentration underestimate glomerular filtration rate in renal transplant patients. Clin Chem 1999; 45: 18661868

63. Fanos V, Mussap M, Plebani M, Cataldi L. Cystatin C in paediatric nephrology. Present situation and prospects. Minerva Pediatr 1999; 51 (5): 167177

64. Catadi L, Mussap M, Bertelli L et al. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999; 16(6): 287295

65. Bjarnadottir M, Crubb A, Olafsson I. Promotermediated dexamethasoneinduced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995; 55: 617623

66. Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentration in renal transplant patients. Clin Chem 2001; 47: 20552059

67. Cimerman N, Brgurjan PM, Krasovec M et al. Serum cystatin C, a potent inhibitor of cysteine proteinase, is elevated in asthmatic patients. Clin Chim Acta 2000; 300: 8395

68. Kos J, ‘tabuc B, Cimerman N, Brunner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression [Letter]. Clin Chem 1998; 44: 25562557

69. Knight EL, Verhave JC, Spigelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65 (4): 14161421

70. Sjostrom J, Tidman M, Jones I. Determination of the production rate and nonrenal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 2005; 65(2): 111124

71. Norlund L, Grubb A, Fex G et al. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998; 36: 175178

72. Bostom AG, Bausserman L, Jacques PF et al. Cystatine C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. Arterioscler Thromb Vasc Biol 1999a; 19: 22412244

73. Aras O, Tsal MY, Hanson NQ et al. Cystatin C is an independent predictor of fasting and postmethionine load total homocysteine concentrations among stable renal transplant recipients. Clin Chem 2001; 47(7): 12631268

74. Bostom AG, Gohn RY, Bausserman L et al. Serum cystatine C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine. J Am Soc Nephrol 1999; 10: 164166

75. HergetRosental S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004c; 66 (3): 11151122

76. Ahlstrom A, Tallgren M, Peltonen S, Pettila V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004; 62(5): 344350

77. John GT, Fleming JJ, Talaulikar GS et al. Measurement of renal function in kidney donors using serum cystatin C and 2microglobulin. Ann Clin Biochem 2003; 40: 656658


Для цитирования:


Смирнов А.В., Каюков И.Г., Есаян А.М., Кучер А.Г., Дегтерева О.А. ПРОБЛЕМА ОЦЕНКИ СКОРОСТИ КЛУБОЧКОВОЙ ФИЛЬТРАЦИИ В СОВРЕМЕННОЙ НЕФРОЛОГИИ: НОВЫЙ ИНДИКАТОР ЦИСТАТИН С. Нефрология. 2005;9(3):16-27. https://doi.org/10.24884/1561-6274-2005-9-3-16-27

For citation:


Smirnov A.V., Kayukov I.G., Essaian A.M., Kucher A.G., Degtereva O.A. THE PROBLEM OF ASSESSMENT OF GLOMERULAR FILTRATION RATE IN MODERN NEPHROLOGY: A NEW INDICATOR CYSTATIN C. Nephrology (Saint-Petersburg). 2005;9(3):16-27. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-3-16-27

Просмотров: 81


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)